Skip to main
BIOL
BIOL logo

BIOLASE (BIOL) Earnings Dates & Reports

BIOLASE (BIOL) Most Recent Earnings

Report DateNov 6, 2024
Period EndingQ3 2024
Est. EPS-$0.06
Actual EPS-$0.04
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BIOLASE (BIOL) Earnings per Share (EPS) History

Signup for full access
Browse free

BIOLASE (BIOL) Latest Earnings

The value each BIOL share was expected to gain vs. the value each share gained.

BIOLASE (BIOL) reported its most recent earnings on Nov 6, 2024 for Q3 2024, posting earnings per share (EPS) of -$0.04. This exceeded analysts' expectations of -$0.06 by 33.33%, marking a Beat.

For comparison, BIOLASE reported EPS of -$3.89 in the same quarter last year.

The company is expected to announce its next earnings report on 11/07/2024, with analysts projecting an EPS of $0.

BIOLASE (BIOL) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2024Nov 6, 2024
-$0.06-$0.04-33.33%
DeckReportListen
Q2 2024Aug 8, 2024
-$0.07-$0.08+14.29%
Q1 2024May 13, 2024
-$0.17-$0.36+111.76%
Q4 2023Mar 21, 2024
-$2.55-$1.76-30.98%
Q3 2023Nov 9, 2023
-$1.85-$3.89+110.27%
View all

BIOLASE (BIOL) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the BIOLASE’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 8, 2024
May 13, 2024
Mar 21, 2024
Nov 9, 2023

BIOLASE (BIOL) Earnings FAQs

BIOLASE (BIOL) last reported earnings on Nov 6, 2024 for Q3 2024, posting an EPS of -$0.04, which Beat the estimate of -$0.06 by 33.33%.

For Q3 2024, BIOLASE (BIOL) reported an EPS of -$0.04, exceeding analysts' estimate of -$0.06 by 33.33%.

For Q3 2024, BIOLASE (BIOL) Beat expectations with an actual EPS of -$0.04 vs. an estimated EPS of -$0.06.

Following the last earnings report on Nov 6, 2024, BIOLASE (BIOL)'s stock price moved — from — to —.

The next BIOLASE (BIOL) earnings call is scheduled for Nov. 7, 2024, where executives will discuss financial results and outlook.

BIOLASE (BIOL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.